Temozolomide
Who holds supplier records for Temozolomide? 19 organisations hold a current record for Temozolomide: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (3), Germany (1), Taiwan (1) and 5 other countries (5); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Temozolomide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/temozolomide
Reading the evidence
- 19 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (19)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Temozolomide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- EXCELLA GMBH AND CO KGGermanyCEP Company GMP cert on recordActive DMF 26032 · latest filing Aug 2012
- Formosa Laboratories, Inc.TaiwanCEP Company GMP cert on recordActive DMF 23158 · latest filing Oct 2009
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 25344 · latest filing Oct 2011
- SHILPA PHARMA LIFESCIENCES LTDIndiaCEPActive DMF 23479 · latest filing Jan 2010
- WAVELENGTH ENTERPRISES LTDIsraelCEP Company GMP cert on recordActive DMF 19347 · latest filing Apr 2006
- Ampac Fine ChemicalsUnited StatesActive DMF 28580 · latest filing Sept 2014
- BEIJING LUNARSUN PHARMACEUTICAL CO LTDActive DMF 24352 · latest filing Nov 2010
- CHEMWERTH INCFranceActive DMF 23547 · latest filing Feb 2010
- GLOPEC INTERNATIONAL INCCanadaActive DMF 24173 · latest filing Aug 2010
- Hubei Haosun Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 27715 · latest filing Oct 2013
- ITF CHEMICAL LTDABrazilActive DMF 26534 · latest filing Oct 2012
- JIANGSU TASLY DIYI PHARMACEUTICAL CO LTDChinaActive DMF 21669 · latest filing May 2008
- LEE FINE CHEM PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 44420 · latest filing Jul 2026
- Reliance Life Sciences Pvt. Ltd.India Company GMP cert on recordActive DMF 22775 · latest filing May 2009
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 23553 · latest filing Mar 2010
- SYNTHIMED LABS PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 24298 · latest filing Dec 2010
- IndiaCEP
- IndiaCEP
- Suzhou Lixin Pharmaceutical Co., Ltd.ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (8)
Certificates of Suitability on the EDQM register for Temozolomide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad | IN | CEP 2019-053 - Rev 01 Temozolomide | Mar 2026 | — |
| EXCELLA GMBH & CO. KG Feucht | DE | CEP 2018-246 - Rev 04 Temozolomide | Sept 2025 | Inspected Apr 2026 Germany |
| FORMOSA LABORATORIES, INC. Taoyuan | TW | CEP 2017-245 - Rev 02 Temozolomide | Jul 2025 | Inspected May 2025 Poland |
| SHILPA PHARMA LIFESCIENCES LIMITED Raichur | IN | CEP 2016-277 - Rev 01 Temozolomide | Jul 2025 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2017-270 - Rev 02 Temozolomide, Form-III | Feb 2025 | — |
| SHIVALIK RASAYAN LIMITED New Delhi | IN | CEP 2021-394 - Rev 00 Temozolomide | Nov 2023 | — |
| WAVELENGTH ENTERPRISES LTD. Petah Tikva | IL | CEP 2020-426 - Rev 01 Temozolomide | Sept 2023 | — |
| SUZHOU LIXIN PHARMACEUTICAL CO., LTD. Suzhou | CN | R0-CEP 2020-359 - Rev 00 Temozolomide | Apr 2022 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (1)
Organisations whose Type II DMFs for Temozolomide are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 29028 · filed Jan 2015
Overview
Temozolomide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL810).
Chemical identity
- IUPAC name
- 3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
- Canonical SMILES
- CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
- InChIKey
- BPEGJWRSRHCHSN-UHFFFAOYSA-N
- Synonyms
- CCRG-81045, M-39831, M&B 39831, M&B-39831, Methazolastone, Mk-7365, NSC-362856, SCH 52365, SCH-52365, Temodal, Temodar, Temomedac
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Alkylating Drug
- Mechanism of action
- Alkylating Activity
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Temozolomide?
19 organisations hold an active US FDA Type II Drug Master File or a CEP for Temozolomide: EXCELLA GMBH AND CO KG (Germany), Formosa Laboratories, Inc. (Taiwan), Hetero Labs Limited (India), SHILPA PHARMA LIFESCIENCES LTD (India), WAVELENGTH ENTERPRISES LTD (Israel), Ampac Fine Chemicals (United States), BEIJING LUNARSUN PHARMACEUTICAL CO LTD and CHEMWERTH INC (France), and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Temozolomide Drug Master Files are active?
EXCELLA GMBH AND CO KG (DMF 26032), Formosa Laboratories, Inc. (DMF 23158), Hetero Labs Limited (DMF 25344), SHILPA PHARMA LIFESCIENCES LTD (DMF 23479), WAVELENGTH ENTERPRISES LTD (DMF 19347), Ampac Fine Chemicals (DMF 28580), BEIJING LUNARSUN PHARMACEUTICAL CO LTD (DMF 24352) and CHEMWERTH INC (DMF 23547) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Temozolomide records mean?
1 organisation has only inactive Type II DMFs for Temozolomide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Temozolomide have a European Certificate of Suitability?
Yes. 8 organisations hold a valid CEP for Temozolomide on the EDQM register, including BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED Hyderabad (IN), EXCELLA GMBH & CO. KG Feucht (DE), FORMOSA LABORATORIES, INC. Taoyuan (TW), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), HETERO LABS LIMITED Hyderabad (IN) and SHIVALIK RASAYAN LIMITED New Delhi (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Temozolomide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Temozolomide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.